Alnylam Pharmaceuticals Stock Forward View
| A1LN34 Stock | BRL 86.40 0.00 0.00% |
Alnylam Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Alnylam Pharmaceuticals stock prices and determine the direction of Alnylam Pharmaceuticals's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Alnylam Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the value of RSI of Alnylam Pharmaceuticals' share price is approaching 30. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Alnylam Pharmaceuticals, making its price go up or down. Momentum 30
Sell Stretched
Oversold | Overbought |
Using Alnylam Pharmaceuticals hype-based prediction, you can estimate the value of Alnylam Pharmaceuticals from the perspective of Alnylam Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Alnylam Pharmaceuticals on the next trading day is expected to be 84.03 with a mean absolute deviation of 3.43 and the sum of the absolute errors of 209.38. Alnylam Pharmaceuticals after-hype prediction price | BRL 86.4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Alnylam |
Alnylam Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Alnylam price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Alnylam using various technical indicators. When you analyze Alnylam charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Alnylam Pharmaceuticals Naive Prediction Price Forecast For the 20th of February
Given 90 days horizon, the Naive Prediction forecasted value of Alnylam Pharmaceuticals on the next trading day is expected to be 84.03 with a mean absolute deviation of 3.43, mean absolute percentage error of 15.65, and the sum of the absolute errors of 209.38.Please note that although there have been many attempts to predict Alnylam Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Alnylam Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Alnylam Pharmaceuticals Stock Forecast Pattern
| Backtest Alnylam Pharmaceuticals | Alnylam Pharmaceuticals Price Prediction | Research Analysis |
Alnylam Pharmaceuticals Forecasted Value
In the context of forecasting Alnylam Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Alnylam Pharmaceuticals' downside and upside margins for the forecasting period are 80.61 and 87.44, respectively. We have considered Alnylam Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Alnylam Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Alnylam Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 120.8611 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 3.4325 |
| MAPE | Mean absolute percentage error | 0.0326 |
| SAE | Sum of the absolute errors | 209.3848 |
Predictive Modules for Alnylam Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Alnylam Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Alnylam Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Alnylam Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Alnylam Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Alnylam Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Alnylam Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Alnylam Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Alnylam Pharmaceuticals' historical news coverage. Alnylam Pharmaceuticals' after-hype downside and upside margins for the prediction period are 82.96 and 89.84, respectively. We have considered Alnylam Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Alnylam Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Alnylam Pharmaceuticals is based on 3 months time horizon.
Alnylam Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Alnylam Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Alnylam Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Alnylam Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.55 | 3.41 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
86.40 | 86.40 | 0.00 |
|
Alnylam Pharmaceuticals Hype Timeline
Alnylam Pharmaceuticals is presently traded for 86.40on Sao Paulo Exchange of Brazil. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Alnylam is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is presently at -0.55%. %. The volatility of related hype on Alnylam Pharmaceuticals is about 0.0%, with the expected price after the next announcement by competition of 86.40. The company recorded a loss per share of 37.45. Alnylam Pharmaceuticals had not issued any dividends in recent years. Assuming the 90 days trading horizon the next expected press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Alnylam Pharmaceuticals to cross-verify your projections. For information on how to trade Alnylam Stock refer to our How to Trade Alnylam Stock guide.Alnylam Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Alnylam Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Alnylam Pharmaceuticals' future price movements. Getting to know how Alnylam Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Alnylam Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| A1IV34 | Apartment Investment and | 0.00 | 0 per month | 1.02 | 0.05 | 2.01 | (1.92) | 10.09 | |
| M1NS34 | Monster Beverage | 0.00 | 0 per month | 1.12 | 0.14 | 2.26 | (2.04) | 7.52 | |
| H1CA34 | HCA Healthcare | 0.00 | 0 per month | 1.66 | 0.08 | 4.11 | (3.20) | 16.50 | |
| H1RL34 | Hormel Foods | 0.00 | 0 per month | 0.68 | 0.08 | 1.84 | (1.01) | 11.72 | |
| CLOV34 | Clover Health Investments | 0.00 | 0 per month | 0.00 | (0.1) | 5.69 | (5.28) | 25.01 | |
| O2HI34 | Omega Healthcare Investors | 0.00 | 0 per month | 1.06 | 0.06 | 3.11 | (3.10) | 10.01 | |
| FIQE3 | Unifique Telecomunicaes SA | 0.00 | 0 per month | 1.92 | 0.13 | 3.10 | (3.04) | 11.69 |
Other Forecasting Options for Alnylam Pharmaceuticals
For every potential investor in Alnylam, whether a beginner or expert, Alnylam Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Alnylam Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Alnylam. Basic forecasting techniques help filter out the noise by identifying Alnylam Pharmaceuticals' price trends.Alnylam Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alnylam Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Alnylam Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Alnylam Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Alnylam Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Alnylam Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Alnylam Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Alnylam Pharmaceuticals stock market strength indicators, traders can identify Alnylam Pharmaceuticals entry and exit signals to maximize returns.
Alnylam Pharmaceuticals Risk Indicators
The analysis of Alnylam Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Alnylam Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting alnylam stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.94 | |||
| Standard Deviation | 3.28 | |||
| Variance | 10.76 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Alnylam Pharmaceuticals
The number of cover stories for Alnylam Pharmaceuticals depends on current market conditions and Alnylam Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Alnylam Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Alnylam Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Alnylam Pharmaceuticals Short Properties
Alnylam Pharmaceuticals' future price predictability will typically decrease when Alnylam Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Alnylam Pharmaceuticals often depends not only on the future outlook of the potential Alnylam Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alnylam Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Float Shares | 118.15M | |
| Average Daily Volume Last 10 Day | 502 | |
| Average Daily Volume In Three Month | 920 |
Additional Information and Resources on Investing in Alnylam Stock
When determining whether Alnylam Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alnylam Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alnylam Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alnylam Pharmaceuticals Stock:Check out Historical Fundamental Analysis of Alnylam Pharmaceuticals to cross-verify your projections. For information on how to trade Alnylam Stock refer to our How to Trade Alnylam Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.